The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model

Urological Research

Volumn 27, Issue 3, 1999, Pages 194-199

  Yasui, Takahiro ^a   Fujita, Keiji ^a   Sato, Motohiko ^c   Sugimoto, Mizuo ^c   Iguchi, Masanori ^b   Nomura, Shintaro ^c   Kohri, Kenjiro ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b Kaizuka City Hospital   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Calcium oxalate; Ethylene glycol; Kampo; Osteopontin; Takusha; Urolithiasis

Indexed keywords

COLECALCIFEROL; ETHYLENE GLYCOL; KAMPO; OSTEOPONTIN; TAKUSHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM OXALATE STONE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; IMMUNOHISTOCHEMISTRY; INTRAGASTRIC DRUG ADMINISTRATION; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STONE DISSOLUTION;

ANIMALS; CALCIUM OXALATE; CHOLECALCIFEROL; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; ETHYLENE GLYCOL; GENE EXPRESSION; KIDNEY CALCULI; MALE; OSTEOPONTIN; RATS; RATS, WISTAR; SIALOGLYCOPROTEINS;

EID: 0033066390     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400050109     Document Type: Article

References (21)

1. Ahlstrand C, Tiselius HG (1981) Renal stone disease in a Swedish district during one year. Scand J Urol Nephrol 15:143
2. Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW (1993) Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner 22:147
3. Boyce WH (1968) Organic matrix of human urinary concretions. Am J Med 45:673
4. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294
5. Denhardt DT, Guo X (1993) Osteopontin: a protein with diverse functions. FASEB J 7:1475
6. Dussol B, Geider S, Lilova A, Leonetti F, Dupuy P, Daudon M, Berland Y, Dagorn JC, Verdier JM (1995) Analysis of the soluble organic matrix of five morphologically different kidney stones. Urol Res 23:45
7. Fraser J, Campbell DJ (1972) Indirect measure of oxalic acid in urine by atomic absorption spectrophotometry. Clin Biochem 5:99
8. Johnson CM, Wilson DM, O'Fallon WM, Malek RS, Kurland LT (1979) Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int 16:624
9. Kohri K, Suzuki Y, Yoshida K, Yamamoto K, Amasaki N, Yamate T, Umekawa T, Iguchi M, Shinohara H, Kurita T (1992) Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin. Biochem Biophys Res Commun 184:859
10. Kohri K, Nomura S, Kitamura Y, Nagata T, Yoshioka K, Iguchi M, Yamate T, Umekawa T, Suzuki Y, Shinohara H, Kurita T (1993) Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268:15180
11. Koide T, Yamaguchi S, Utsunomiya M, Yoshioka T, Sugiyama K (1995) The inhibitory effect of kampou extracts on in vitro calcium oxalate crystallization and in vivo stone formation in an animal model. Int J Urol 2:81
12. Kurita T, Yachiku S, Kohri K (1981) Analysis of the effects of the choreito on the spontaneous discharge of ureteral calculi. Acta Urol Jpn 27:801
13. Lieske JC, Hammes MS, Hoyer JR, Toback FG (1997) Renal cell osteopontin production is stimulated by calcium oxalate monohydrate crystals. Kidney Int 51:679
14. Mckee MD, Nanci A, Khan SR (1995) Ultrastructual immnodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10:1913
15. Nomura S, Wills AJ, Edwards DR, Heath JK, Hogan BL (1988) Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol 106:441
16. Okada Y, Kawamura J, Yih JK, Yoshida O (1984) Experimental model for calcium oxalate urolithiasis. In: Ryall R, Brockis JG, Marshall V, Finlayson B (eds) Urinary stone. Churchill Livingstone, Edinburgh, p 378
17. Pak CY (1991) Etiology and treatment of urolithiasis. Am J Kidney Dis 18:624
18. Pizzolato P (1971) Mercurous nitrate as a histochemical reagent for calcium phosphate in bone and pathological calcification and for calcium oxalate. Histochem J 3:463
19. Saavedra RA (1994) The roles of autophosphorylation and phosphorylation in the life of osteopontin. Bioassays 16:913
20. Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG, Hoyer JR (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426
21. Utsunomiya M, Koide T, Yamaguchi S, Yoshioka T, Sonoda T (1991) The effect of kanpou medicine on the growth and aggregation of calcium oxalate crystals in vitro. Acta Urol Jpn 37:1097